» Articles » PMID: 9339931

Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990s: Pathology, Complications, and Outcomes

Overview
Journal Ann Surg
Specialty General Surgery
Date 1997 Oct 27
PMID 9339931
Citations 607
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The authors reviewed the pathology, complications, and outcomes in a consecutive group of 650 patients undergoing pancreaticoduodenectomy in the 1990s.

Summary Background Data: Pancreaticoduodenectomy has been used increasingly in recent years to resect a variety of malignant and benign diseases of the pancreas and periampullary region.

Methods: Between January 1990 and July 1996, inclusive, 650 patients underwent pancreaticoduodenal resection at The Johns Hopkins Hospital. Data were recorded prospectively on all patients. All pathology specimens were reviewed and categorized. Statistical analyses were performed using both univariate and multivariate models.

Results: The patients had a mean age of 63 +/- 12.8 years, with 54% male and 91% white. The number of resections per year rose from 60 in 1990 to 161 in 1995. Pathologic examination results showed pancreatic cancer (n = 282; 43%), ampullary cancer (n = 70; 11%), distal common bile duct cancer (n = 65; 10%), duodenal cancer (n = 26; 4%), chronic pancreatitis (n = 71; 11%), neuroendocrine tumor (n = 31; 5%), periampullary adenoma (n = 21; 3%), cystadenocarcinoma (n = 14; 2%), cystadenoma (n = 25; 4%), and other (n = 45; 7%). The surgical procedure involved pylorus preservation in 82%, partial pancreatectomy in 95%, and portal or superior mesenteric venous resection in 4%. Pancreatic-enteric reconstruction, when appropriate, was via pancreaticojejunostomy in 71% and pancreaticogastrostomy in 29%. The median intraoperative blood loss was 625 mL, median units of red cells transfused was zero, and the median operative time was 7 hours. During this period, 190 consecutive pancreaticoduodenectomies were performed without a mortality. Nine deaths occurred in-hospital or within 30 days of operation (1.4% operative mortality). The postoperative complication rate was 41%, with the most common complications being early delayed gastric emptying (19%), pancreatic fistula (14%), and wound infection (10%). Twenty-three patients required reoperation in the immediate postoperative period (3.5%), most commonly for bleeding, abscess, or dehiscence. The median postoperative length of stay was 13 days. A multivariate analysis of the 443 patients with periampullary adenocarcinoma indicated that the most powerful independent predictors favoring long-term survival included a pathologic diagnosis of duodenal adenocarcinoma, tumor diameter <3 cm, negative resection margins, absence of lymph node metastases, well-differentiated histology, and no reoperation.

Conclusions: This single institution, high-volume experience indicates that pancreaticoduodenectomy can be performed safely for a variety of malignant and benign disorders of the pancreas and periampullary region. Overall survival is determined largely by the pathology within the resection specimen.

Citing Articles

Hypnotic drug use and intraoperative fluid balance associated with postoperative delirium following pancreatic surgery: A retrospective, observational, single-center study.

Huang Z, Zhang J, Xu X, Wang Y, Lu X, Luo Y PLoS One. 2025; 20(3):e0319380.

PMID: 40053567 PMC: 11888130. DOI: 10.1371/journal.pone.0319380.


PACT-UK (PAncreatic Cancer reporting Template-UK): a cross-specialty multi-institutional consensus panel development of a standardised radiological reporting proforma for pancreatic cancer.

Moir J, Radhakrishna G, Valle J, Al-Adhami A, Albazaz R BMJ Oncol. 2025; 2(1):e000055.

PMID: 39886489 PMC: 11203077. DOI: 10.1136/bmjonc-2023-000055.


An Overview for Clinicians on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas.

Moris D, Liapis I, Gupta P, Ziogas I, Karachaliou G, Dimitrokallis N Cancers (Basel). 2024; 16(22).

PMID: 39594780 PMC: 11593033. DOI: 10.3390/cancers16223825.


A method of "Noninjecting Resection using Bipolar Soft coagulation mode; NIRBS" for superficial non-ampullary duodenal epithelial tumor: a pilot study.

Tokuhara M, Sano Y, Watanabe Y, Nakata H, Nakahira H, Furukawa S BMC Gastroenterol. 2024; 24(1):343.

PMID: 39354393 PMC: 11446073. DOI: 10.1186/s12876-024-03439-w.


Stent A pancreaticojejunostomy after pancreatoduodenectomy: Is it always necessary?.

Symeonidis D, Zacharoulis D, Tzovaras G, Kissa L, Samara A, Petsa E World J Methodol. 2024; 14(3):90164.

PMID: 39310242 PMC: 11230077. DOI: 10.5662/wjm.v14.i3.90164.


References
1.
Talamini M, Moesinger R, Pitt H, Sohn T, Hruban R, Lillemoe K . Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg. 1997; 225(5):590-9; discussion 599-600. PMC: 1190801. DOI: 10.1097/00000658-199705000-00015. View

2.
Bottger T, Storkel S, Wellek S, Stockle M, Junginger T . Factors influencing survival after resection of pancreatic cancer. A DNA analysis and a histomorphologic study. Cancer. 1994; 73(1):63-73. DOI: 10.1002/1097-0142(19940101)73:1<63::aid-cncr2820730113>3.0.co;2-p. View

3.
Cullen J, Sarr M, Ilstrup D . Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management. Am J Surg. 1994; 168(4):295-8. DOI: 10.1016/s0002-9610(05)80151-5. View

4.
Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S . Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996; 224(4):463-73; discussion 473-5. PMC: 1235406. DOI: 10.1097/00000658-199610000-00005. View

5.
CRILE Jr G . The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet. 1970; 130(6):1049-53. View